APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buspirone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Buspirone Industry Growth and Trends Forecast to 2032

19 December 2025102 pages

Choose your research edition.

Industry ResearchBuspirone Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Buspirone Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Buspirone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buspirone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Buspirone Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Buspirone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buspirone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Buspirone include Teva, Novartis, Mylan, Wockhardt, Watson Laboratories, Orion Corporation, Laboratoires Servier, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Buspirone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Buspirone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Buspirone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Buspirone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Buspirone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Buspirone Market by Company

Teva

Novartis

Mylan

Wockhardt

Watson Laboratories

Orion Corporation

Laboratoires Servier

Hikma

Dr. Reddy's Laboratories

Cadila Healthcare

Bristol Myers Squibb

Apotex

AMAG Pharmaceuticals

Buspirone Segment by Type

10mg

15mg

30mg

5mg

Buspirone Segment by Application

Hospital

Drug Store

Buspirone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buspirone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buspirone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buspirone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Buspirone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 15mg Table 3. Major Company of 30mg Table 4. Major Company of 5mg Table 5. Global Buspirone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Buspirone Sales by Type (2021-2026) & (K Units) Table 7. Global Buspirone Sales Market Share in Volume by Type (2021-2026) Table 8. Global Buspirone Sales by Type (2021-2026) & (US$ Million) Table 9. Global Buspirone Sales Market Share in Value by Type (2021-2026) Table 10. Global Buspirone Price by Type (2021-2026) & (US$/Unit) Table 11. Global Buspirone Sales by Type (2027-2032) & (K Units) Table 12. Global Buspirone Sales Market Share in Volume by Type (2027-2032) Table 13. Global Buspirone Sales by Type (2027-2032) & (US$ Million) Table 14. Global Buspirone Sales Market Share in Value by Type (2027-2032) Table 15. Global Buspirone Price by Type (2027-2032) & (US$/Unit) Table 16. North America Buspirone Sales by Type (2021-2026) & (K Units) Table 17. North America Buspirone Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Buspirone Sales by Type (2021-2026) & (K Units) Table 19. Europe Buspirone Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Buspirone Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Buspirone Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Buspirone Sales by Type (2021-2026) & (K Units) Table 23. Latin America Buspirone Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Buspirone Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Buspirone Sales by Type (2021-2026) & (US$ Million) Table 26. Buspirone Industry Trends Table 27. Buspirone Industry Drivers Table 28. Buspirone Industry Opportunities and Challenges Table 29. Buspirone Industry Restraints Table 30. Global Buspirone Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Buspirone Revenue Market Share by Company (2021-2026) Table 32. Global Buspirone Sales by Company (2021-2026) & (K Units) Table 33. Global Buspirone Sales Share by Company (2021-2026) Table 34. Global Buspirone Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Buspirone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Buspirone Major Company Production Sites and Headquarters Table 37. Global Buspirone Company, Product Type & Application Table 38. Global Buspirone Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Buspirone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Buspirone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Buspirone Sales by Region (2021-2026) & (K Units) Table 43. Global Buspirone Sales Market Share in Volume by Region (2021-2026) Table 44. Global Buspirone Sales by Region (2021-2026) & (US$ Million) Table 45. Global Buspirone Sales Market Share in Value by Region (2021-2026) Table 46. Global Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Buspirone Sales by Region (2027-2032) & (K Units) Table 48. Global Buspirone Sales Market Share in Volume by Region (2027-2032) Table 49. Global Buspirone Sales by Region (2027-2032) & (US$ Million) Table 50. Global Buspirone Sales Market Share in Value by Region (2027-2032) Table 51. Global Buspirone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Buspirone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Buspirone Sales by Application (2021-2026) & (K Units) Table 54. Global Buspirone Sales Market Share in Volume by Application (2021-2026) Table 55. Global Buspirone Sales by Application (2021-2026) & (US$ Million) Table 56. Global Buspirone Sales Market Share in Value by Application (2021-2026) Table 57. Global Buspirone Price by Application (2021-2026) & (US$/Unit) Table 58. Global Buspirone Sales by Application (2027-2032) & (K Units) Table 59. Global Buspirone Sales Market Share in Volume by Application (2027-2032) Table 60. Global Buspirone Sales by Application (2027-2032) & (US$ Million) Table 61. Global Buspirone Sales Market Share in Value by Application (2027-2032) Table 62. Global Buspirone Price by Application (2027-2032) & (US$/Unit) Table 63. North America Buspirone Sales by Application (2021-2026) & (K Units) Table 64. North America Buspirone Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Buspirone Sales by Application (2021-2026) & (K Units) Table 66. Europe Buspirone Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Buspirone Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Buspirone Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Buspirone Sales by Application (2021-2026) & (K Units) Table 70. Latin America Buspirone Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Buspirone Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Buspirone Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Buspirone Product Portfolio Table 77. Teva Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Buspirone Product Portfolio Table 82. Novartis Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Buspirone Product Portfolio Table 87. Mylan Recent Development Table 88. Wockhardt Company Information Table 89. Wockhardt Business Overview Table 90. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Wockhardt Buspirone Product Portfolio Table 92. Wockhardt Recent Development Table 93. Watson Laboratories Company Information Table 94. Watson Laboratories Business Overview Table 95. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Watson Laboratories Buspirone Product Portfolio Table 97. Watson Laboratories Recent Development Table 98. Orion Corporation Company Information Table 99. Orion Corporation Business Overview Table 100. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Orion Corporation Buspirone Product Portfolio Table 102. Orion Corporation Recent Development Table 103. Laboratoires Servier Company Information Table 104. Laboratoires Servier Business Overview Table 105. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Laboratoires Servier Buspirone Product Portfolio Table 107. Laboratoires Servier Recent Development Table 108. Hikma Company Information Table 109. Hikma Business Overview Table 110. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hikma Buspirone Product Portfolio Table 112. Hikma Recent Development Table 113. Dr. Reddy's Laboratories Company Information Table 114. Dr. Reddy's Laboratories Business Overview Table 115. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Dr. Reddy's Laboratories Buspirone Product Portfolio Table 117. Dr. Reddy's Laboratories Recent Development Table 118. Cadila Healthcare Company Information Table 119. Cadila Healthcare Business Overview Table 120. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Cadila Healthcare Buspirone Product Portfolio Table 122. Cadila Healthcare Recent Development Table 123. Bristol Myers Squibb Company Information Table 124. Bristol Myers Squibb Business Overview Table 125. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bristol Myers Squibb Buspirone Product Portfolio Table 127. Bristol Myers Squibb Recent Development Table 128. Apotex Company Information Table 129. Apotex Business Overview Table 130. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Apotex Buspirone Product Portfolio Table 132. Apotex Recent Development Table 133. AMAG Pharmaceuticals Company Information Table 134. AMAG Pharmaceuticals Business Overview Table 135. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AMAG Pharmaceuticals Buspirone Product Portfolio Table 137. AMAG Pharmaceuticals Recent Development Table 138. North America Buspirone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. North America Buspirone Sales by Country (2021-2026) & (K Units) Table 140. North America Buspirone Sales Market Share by Country (2021-2026) Table 141. North America Buspirone Sales Forecast by Country (2027-2032) & (K Units) Table 142. North America Buspirone Sales Market Share Forecast by Country (2027-2032) Table 143. North America Buspirone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Buspirone Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Buspirone Market Share by Country (2021-2026) Table 146. North America Buspirone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Buspirone Market Share Forecast by Country (2027-2032) Table 148. Europe Buspirone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Europe Buspirone Sales by Country (2021-2026) & (K Units) Table 150. Europe Buspirone Sales Market Share by Country (2021-2026) Table 151. Europe Buspirone Sales Forecast by Country (2027-2032) & (K Units) Table 152. Europe Buspirone Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Buspirone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Buspirone Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Buspirone Market Share by Country (2021-2026) Table 156. Europe Buspirone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Buspirone Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Buspirone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Buspirone Sales by Country (2021-2026) & (K Units) Table 160. Asia-Pacific Buspirone Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Buspirone Sales Forecast by Country (2027-2032) & (K Units) Table 162. Asia-Pacific Buspirone Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Buspirone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Buspirone Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Buspirone Market Share by Country (2021-2026) Table 166. Asia-Pacific Buspirone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Buspirone Market Share Forecast by Country (2027-2032) Table 168. Latin America Buspirone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Latin America Buspirone Sales by Country (2021-2026) & (K Units) Table 170. Latin America Buspirone Sales Market Share by Country (2021-2026) Table 171. Latin America Buspirone Sales Forecast by Country (2027-2032) & (K Units) Table 172. Latin America Buspirone Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Buspirone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Buspirone Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Buspirone Market Share by Country (2021-2026) Table 176. Latin America Buspirone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Buspirone Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Buspirone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Buspirone Sales by Country (2021-2026) & (K Units) Table 180. Middle East and Africa Buspirone Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Buspirone Sales Forecast by Country (2027-2032) & (K Units) Table 182. Middle East and Africa Buspirone Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Buspirone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Buspirone Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Buspirone Market Share by Country (2021-2026) Table 186. Middle East and Africa Buspirone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Buspirone Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Buspirone Distributors List Table 191. Buspirone Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Buspirone Image Figure 2. Global Buspirone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buspirone Market Size (2021-2032) & (US$ Million) Figure 4. Global Buspirone Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 15mg Image Figure 8. Global 15mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 30mg Image Figure 10. Global 30mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 5mg Image Figure 12. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Buspirone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Buspirone Market Share by Type 2025 VS 2032 Figure 15. North America Buspirone Sales Market Share in Volume by Type in 2025 Figure 16. North America Buspirone Sales Market Share in Value by Type in 2025 Figure 17. Europe Buspirone Sales Market Share in Volume by Type in 2025 Figure 18. Europe Buspirone Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Buspirone Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Buspirone Sales Market Share in Value by Type in 2025 Figure 21. Latin America Buspirone Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Buspirone Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Buspirone Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Buspirone Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Buspirone Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Drug Store Image Figure 30. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Buspirone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Buspirone Market Share by Application 2025 VS 2032 Figure 33. North America Buspirone Sales Market Share in Volume by Application in 2025 Figure 34. North America Buspirone Sales Market Share in Value by Application in 2025 Figure 35. Europe Buspirone Sales Market Share in Volume by Application in 2025 Figure 36. Europe Buspirone Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Buspirone Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Buspirone Sales Market Share in Value by Application in 2025 Figure 39. Latin America Buspirone Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Buspirone Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Buspirone Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Buspirone Sales Market Share in Value by Application in 2025 Figure 43. North America Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Buspirone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Buspirone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Buspirone Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Buspirone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Buspirone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Buspirone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Buspirone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Buspirone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Buspirone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Buspirone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Buspirone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Buspirone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Buspirone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Buspirone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Buspirone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Buspirone Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Buspirone Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Buspirone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 15mg
  • 30mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Wockhardt
  • Watson Laboratories
  • Orion Corporation
  • Laboratoires Servier
  • Hikma
  • Dr. Reddy's Laboratories
  • Cadila Healthcare
  • Bristol Myers Squibb
  • Apotex
  • AMAG Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buspirone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Buspirone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Buspirone Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 15mg
  8. 1.3.3 30mg
  9. 1.3.4 5mg
  10. 1.4 Global Buspirone Market Size by Type
  11. 1.4.1 Global Buspirone Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Buspirone Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Buspirone Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Buspirone Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Buspirone Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Buspirone Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Buspirone Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Buspirone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Buspirone Industry Trends
  2. 2.2 Buspirone Industry Drivers
  3. 2.3 Buspirone Industry Opportunities and Challenges
  4. 2.4 Buspirone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Buspirone Revenue (2021-2026)
  2. 3.2 Global Top Players by Buspirone Sales (2021-2026)
  3. 3.3 Global Top Players by Buspirone Price (2021-2026)
  4. 3.4 Global Buspirone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Buspirone Major Company Production Sites & Headquarters
  6. 3.6 Global Buspirone Company, Product Type & Application
  7. 3.7 Global Buspirone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Buspirone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Buspirone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Buspirone Tier 1, Tier 2, and Tier 3
4 Buspirone Regional Status and Outlook
  1. 4.1 Global Buspirone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Buspirone Historic Market Size by Region
  3. 4.2.1 Global Buspirone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Buspirone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Buspirone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Buspirone Forecasted Market Size by Region
  7. 4.3.1 Global Buspirone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Buspirone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Buspirone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Buspirone by Application
  1. 5.1 Buspirone Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Buspirone Market Size by Application
  5. 5.2.1 Global Buspirone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Buspirone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Buspirone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Buspirone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Buspirone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Buspirone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Buspirone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Buspirone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Buspirone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Buspirone Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Buspirone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Buspirone Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Buspirone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Buspirone Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Wockhardt
  20. 6.4.1 Wockhardt Company Information
  21. 6.4.2 Wockhardt Business Overview
  22. 6.4.3 Wockhardt Buspirone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wockhardt Buspirone Product Portfolio
  24. 6.4.5 Wockhardt Recent Developments
  25. 6.5 Watson Laboratories
  26. 6.5.1 Watson Laboratories Company Information
  27. 6.5.2 Watson Laboratories Business Overview
  28. 6.5.3 Watson Laboratories Buspirone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Watson Laboratories Buspirone Product Portfolio
  30. 6.5.5 Watson Laboratories Recent Developments
  31. 6.6 Orion Corporation
  32. 6.6.1 Orion Corporation Company Information
  33. 6.6.2 Orion Corporation Business Overview
  34. 6.6.3 Orion Corporation Buspirone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Orion Corporation Buspirone Product Portfolio
  36. 6.6.5 Orion Corporation Recent Developments
  37. 6.7 Laboratoires Servier
  38. 6.7.1 Laboratoires Servier Company Information
  39. 6.7.2 Laboratoires Servier Business Overview
  40. 6.7.3 Laboratoires Servier Buspirone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Laboratoires Servier Buspirone Product Portfolio
  42. 6.7.5 Laboratoires Servier Recent Developments
  43. 6.8 Hikma
  44. 6.8.1 Hikma Company Information
  45. 6.8.2 Hikma Business Overview
  46. 6.8.3 Hikma Buspirone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hikma Buspirone Product Portfolio
  48. 6.8.5 Hikma Recent Developments
  49. 6.9 Dr. Reddy's Laboratories
  50. 6.9.1 Dr. Reddy's Laboratories Company Information
  51. 6.9.2 Dr. Reddy's Laboratories Business Overview
  52. 6.9.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
  54. 6.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 6.10 Cadila Healthcare
  56. 6.10.1 Cadila Healthcare Company Information
  57. 6.10.2 Cadila Healthcare Business Overview
  58. 6.10.3 Cadila Healthcare Buspirone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cadila Healthcare Buspirone Product Portfolio
  60. 6.10.5 Cadila Healthcare Recent Developments
  61. 6.11 Bristol Myers Squibb
  62. 6.11.1 Bristol Myers Squibb Company Information
  63. 6.11.2 Bristol Myers Squibb Business Overview
  64. 6.11.3 Bristol Myers Squibb Buspirone Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bristol Myers Squibb Buspirone Product Portfolio
  66. 6.11.5 Bristol Myers Squibb Recent Developments
  67. 6.12 Apotex
  68. 6.12.1 Apotex Company Information
  69. 6.12.2 Apotex Business Overview
  70. 6.12.3 Apotex Buspirone Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Apotex Buspirone Product Portfolio
  72. 6.12.5 Apotex Recent Developments
  73. 6.13 AMAG Pharmaceuticals
  74. 6.13.1 AMAG Pharmaceuticals Company Information
  75. 6.13.2 AMAG Pharmaceuticals Business Overview
  76. 6.13.3 AMAG Pharmaceuticals Buspirone Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AMAG Pharmaceuticals Buspirone Product Portfolio
  78. 6.13.5 AMAG Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Buspirone Sales by Country
  2. 7.1.1 North America Buspirone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Buspirone Sales by Country (2021-2026)
  4. 7.1.3 North America Buspirone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Buspirone Market Size by Country
  6. 7.2.1 North America Buspirone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Buspirone Market Size by Country (2021-2026)
  8. 7.2.3 North America Buspirone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Buspirone Sales by Country
  2. 8.1.1 Europe Buspirone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Buspirone Sales by Country (2021-2026)
  4. 8.1.3 Europe Buspirone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Buspirone Market Size by Country
  6. 8.2.1 Europe Buspirone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Buspirone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Buspirone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Buspirone Sales by Country
  2. 9.1.1 Asia-Pacific Buspirone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Buspirone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Buspirone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Buspirone Market Size by Country
  6. 9.2.1 Asia-Pacific Buspirone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Buspirone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Buspirone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Buspirone Sales by Country
  2. 10.1.1 South America Buspirone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Buspirone Sales by Country (2021-2026)
  4. 10.1.3 South America Buspirone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Buspirone Market Size by Country
  6. 10.2.1 South America Buspirone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Buspirone Market Size by Country (2021-2026)
  8. 10.2.3 South America Buspirone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Buspirone Sales by Country
  2. 11.1.1 Middle East and Africa Buspirone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Buspirone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Buspirone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Buspirone Market Size by Country
  6. 11.2.1 Middle East and Africa Buspirone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Buspirone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Buspirone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Buspirone Value Chain Analysis
  2. 12.1.1 Buspirone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Buspirone Production Mode & Process
  7. 12.2 Buspirone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Buspirone Distributors
  10. 12.2.3 Buspirone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst